India Therapeutic Drug Monitoring Market By Product (Consumables, Equipment), By Technology (Immunoassays, Chromatography-Ms and Others), By Class of Drug, By End User, By Region, Competition, Forecast & Opportunities, FY 2026

The Indian Therapeutic Drug Monitoring Market is forecast to grow from an estimated 85 million in FY 2021 to 119 million by FY 2026 owing to the rising need of maintaining the drug levels in blood for prevention of diseases. Therapeutic drug monitoring is the practice of monitoring drug levels in the blood and maintaining them to an optimum level with the motive of preventing diseases, eradicating toxicity and many other health-related issues.

The Indian Therapeutic Drug Monitoring Market has been gaining traction over years due to the increase in Indian population, especially the old age population. Precision medicines have been taking over normal medicines over the last few years, which has also led to the growth of the market. Furthermore, increasing government funding and novel product launches have fueled the market growth. However, scarcity of competent skillset is expected to hamper the market growth over the course of next five years.

The Indian Therapeutic Drug Monitoring Market is segmented into product, technology, class of drug, end-user, and region. The technology segment is further divided into immunoassays, chromatography-ms and others, out of which, immunoassays segment is expected to dominate the market in FY2021 as it is a precise method and gives more specific results compared to other technologies. Another driving factor of the segment is that it requires minimal maintenance and skills for operation.

The major players operating in the Indian Therapeutic Drug Monitoring Market are Roche Diagnostics India Pvt Ltd, Abbott India Limited, bioMérieux India, Bio-Rad laboratories India Pvt.Ltd, Thermo Fisher Scientific, Danaher Corporation, Siemens Healthineers India, Randox Laboratories (India) Private Limited, Sekisui Chemical India Private Limited, amongst others.

Years considered for this report:

• Historical Years: FY2016 - FY2019
• Base Year: FY2020
• Estimated Year: FY2021
• Forecast Period: FY2022 - FY2026

The Objective of the Study:

• To analyze and estimate the market size of the Indian Therapeutic Drug Monitoring Market from FY2016 to FY2019.
• To estimate and forecast the market size of the Indian Therapeutic Drug Monitoring Market from FY2020 to FY2026.
• To classify and forecast the Indian Therapeutic Drug Monitoring Market based on product, technology, class of drug, end-user, region and company.
• To identify dominant region or segment in the Indian Therapeutic Drug Monitoring Market.
• To identify drivers and challenges for the Indian Therapeutic Drug Monitoring Market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Indian Therapeutic Drug Monitoring Market.
• To conduct pricing analysis for the Indian Therapeutic Drug Monitoring Market.
• To identify and analyze the profile of leading players operating in the Indian Therapeutic Drug Monitoring Market.
• To identify key sustainable strategies adopted by market players in the Indian Therapeutic Drug Monitoring Market.

The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of market players operating across the country. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the service providers which could not be identified due to the limitations of secondary research. The publisher analyzed the service providers, distribution channels and presence of all major players across the country.

The publisher calculated the market size of the Indian Therapeutic Drug Monitoring Market by using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.

Key Target Audience:

• End-users, hospitals, laboratories and other stakeholders
• Government bodies such as regulating authorities and policy makers
• Organizations, forums, and alliances related to therapeutic drug monitoring
• Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as service providers, end-users, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.

Report Scope:
In this report, the Indian Therapeutic Drug Monitoring Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Market, By Product:

• Consumables
• Equipment

Market, By Technology:

• Immunoassays
• Chromatography-Ms
• Others

Market, By Class of Drug:

• Antiepileptic Drugs
• Antiarrhythmic Drugs
• Immunosuppressant Drugs
• Antibiotic Drugs
• Others

Market, By End-User:

• Hospital
• Private Labs

Market, By Region:

• North
• East
• West
• South

Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Indian Therapeutic Drug Monitoring Market.

Available Customizations:
With the given market data, the publisher offers customizations according to a client’s specific needs.